메뉴 건너뛰기
Journal of the College of Physicians and Surgeons Pakistan
Volumn 17, Issue 7, 2007, Pages 448-
Mechanism underlying hypertension and proteinuria caused by bevacizumab
Author keywords

[No Author keywords available]
Indexed keywords

EID: 69049105591     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (7)
References (5)
  • 1
    • 34248173883 scopus 로고    scopus 로고
    • Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
    • Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007; 25: 1539-1544
    • (2007) J Clin Oncol , vol.25 , pp. 1539-1544
    • Giantonio, B.J.1    Catalano, P.J.2    Meropol, N.J.3    O'Dwyer, P.J.4    Mitchell, E.P.5    Alberts, S.R.6
  • 2
    • 34247597779 scopus 로고    scopus 로고
    • Proteinuria in patient receiving anti-VEGF therapy for metastatic renal cell carcinoma
    • Roncone D, Satoskar A, Nadasdy T, Monk JP, Rovin BH, Proteinuria in patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Pract Nephrol 2007; 3: 287-293
    • (2007) Nat Clin Pract Nephrol , vol.3 , pp. 287-293
    • Roncone, D.1    Satoskar, A.2    Nadasdy, T.3    Monk, J.P.4    Rovin, B.H.5
  • 3
    • 34249689557 scopus 로고    scopus 로고
    • VEGF-targeted cancer therapy strategies: Current progress, hurdles and future prospects
    • Duda DG, Batchelor TT, Willett CG, Jain RK. VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects. Trends Mol Med 2007; 13: 223-230
    • (2007) Trends Mol Med , vol.13 , pp. 223-230
    • Duda, D.G.1    Batchelor, T.T.2    Willett, C.G.3    Jain, R.K.4
  • 4
    • 0037373006 scopus 로고    scopus 로고
    • Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
    • Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658
    • (2003) J Clin Invest , vol.111 , pp. 649-658
    • Maynard, S.E.1    Min, J.Y.2    Merchan, J.3    Lim, K.H.4    Li, J.5    Mondal, S.6
  • 5
    • 0037370325 scopus 로고    scopus 로고
    • Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
    • Eremina V, Sood M, Haigh J, Nagy A, Lajoie G. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707-716
    • (2003) J Clin Invest , vol.111 , pp. 707-716
    • Eremina, V.1    Sood, M.2    Haigh, J.3    Nagy, A.4    Lajoie, G.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.